NCT01751451
3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy
Phase: Phase 2
Role: Collaborator
Start: Dec 18, 2012
Completion: Sep 28, 2020